High-Throughput Antibody Expression and Purification
High-Throughput Antibody Expression and Purification
Services
Online Inquiry

High-Throughput Antibody Expression and Purification

Antibody Expression

Accelerate antibody screening and engineering with parallel HEK293 expression and protein A purification for hundreds of monoclonal.

  • Parallel expression of up to hundreds of antibody variants in HEK293 cells
  • Protein A affinity purification with SEC-HPLC purity and ELISA binding QC
  • Customizable project scope from gene synthesis to purified antibody
  • Rapid turnaround timeline defined with your team

Why Choose Our High-Throughput Antibody Service?

Streamlined from sequence to purified antibody with comprehensive quality control.

  • Transient transfection in HEK293 for rapid parallel production
  • Small-scale yields sufficient for screening and lead selection
  • Purity assessed by SEC-HPLC and functional binding by ELISA
  • Project scope tailored to your panel size and application needs
Reproducible
Scalable
Pure
Our Approach

Integrated High-Throughput Pipeline

Combining automated gene synthesis, parallel HEK293 transfection, and affinity purification to deliver purified antibodies for early-stage screening and developability assessment.

Parallel HEK293 Transient Expression

Our high-throughput platform uses transient transfection of HEK293 cells in multi-well plates, reducing hands-on time and resource requirements while producing antibody panels in parallel.

  • Codon-optimized gene synthesis and cloning into mammalian expression vectors
  • Small-scale transfection in 96‑well or 24‑well format
  • Automated liquid handling for reproducible expression

Comprehensive Quality Assessment

Each purified antibody undergoes analytical QC to confirm identity, purity, and functional binding, ensuring suitability for downstream applications.

  • SEC‑HPLC for monomer purity and aggregation assessment
  • ELISA binding assay against target antigen
  • SDS‑PAGE for molecular weight verification
  • Endotoxin testing included as scoped per project

Gene Synthesis & Cloning

We design and synthesize codon‑optimized antibody genes and clone them into expression vectors for consistent, high‑yield production.

Expression & Harvest

Small‑scale transient transfection is performed in parallel, followed by harvest and clarification of culture supernatant for purification.

QC Reporting

A detailed quality report accompanies each purified antibody, including purity, binding activity, and raw data, enabling confident decision‑making.

Deliverables

What You Receive

Purified antibodies, analytical QC data, and a comprehensive project report tailored to your research needs.

Data Deliverables

  • Purified antibody at specified yield (e.g., 0.2 mg per variant)
  • SEC‑HPLC chromatograms and purity report
  • ELISA binding curves and titer data
  • SDS‑PAGE gel images
  • Endotoxin test results (if included in scope)

Reporting & Support

  • Detailed project report with methods and results
  • Raw data files (chromatograms, ELISA reads)
  • Consultation on downstream applications and re‑supply
  • Confidentiality and data ownership per agreement
Service Scope

Customizable Parameters

Each project is defined collaboratively; the table below outlines typical customization options.

ParameterTypical Project Scope
Antibody formatHuman IgG1, IgG2, IgG4; mouse IgG1, IgG2a, IgG2b; or scFv‑Fc as specified
Expression systemHEK293 (transient); alternative hosts assessed case‑by‑case
Starting materialAmino acid sequence provided; or gene synthesis included if sequence is defined
Yield per variantScoped per project (e.g., ≥0.2 mg for screening panels)
Purity target≥90% monomer purity by SEC‑HPLC (typical); higher purity evaluated on request
QC assays includedSEC‑HPLC, SDS‑PAGE, ELISA binding; endotoxin testing added as needed
Number of variantsScalable; confirmed during consultation (dozens to hundreds)
Sample formatPurified antibody in PBS or other buffer; concentration quantified
Workflow

From Sequence to Purified Antibody

A streamlined five‑step process designed for parallel production of antibody panels with minimal turnaround.

Sequence Submission & Gene Synthesis

Client provides antibody heavy‑ and light‑chain sequences. We optimize codons for HEK293 expression and synthesize the genes into expression vectors.

Cloning into Expression Vectors

Synthesized genes are cloned into mammalian expression vectors containing appropriate promoter and signal peptide elements for secretion.

Transient Transfection & Small‑Scale Culture

HEK293 cells are seeded in multi‑well plates, co‑transfected with heavy‑ and light‑chain plasmids, and cultured under controlled conditions for transient expression.

Harvest, Purification & Buffer Exchange

Culture supernatant is harvested, clarified, and passed over a Protein A affinity column. The antibody is eluted, buffer‑exchanged, and concentrated.

Quality Control & Deliverable Packaging

Each purified antibody is analyzed by SEC‑HPLC for purity, SDS‑PAGE for integrity, and ELISA for binding activity. Results are compiled into a project report.

Applications

Where High-Throughput Antibody Production Fits

From early screening to engineering, our service supports key stages of antibody development.

Rapidly assess large variant panels

Express and purify dozens to hundreds of monoclonal antibodies in parallel to identify top binders and functional candidates.

  • Evaluate affinity and specificity against target antigen
  • Rank clones by expression yield and purity
  • Select leads for further characterization

Identify problematic clones early

  • SEC‑HPLC profile points to aggregation or fragmentation
  • ELISA confirms target engagement
  • Yield data informs production scalability

Iterate on sequence‑function relationships

Engineered antibody variants (e.g., format changes, mutations) can be rapidly tested for improved expression or binding properties.

  • Compare IgG subclass, scFv‑Fc, or bispecific variants
  • Test glycoengineered or Fc‑mutated panels
  • Accelerate hit‑to‑lead optimization cycles
FAQ

Common Questions

Find answers about scope, turnaround, and data usage.

  • We routinely produce full-length human IgG1, IgG2, IgG4 and mouse IgG1, IgG2a, IgG2b. Other formats such as scFv-Fc or bispecific antibodies can be accommodated after consultation. The exact format is scoped per project.

  • Each purified antibody is analyzed by SEC-HPLC (monomer purity), SDS-PAGE (integrity), and ELISA (binding activity against the provided antigen). Additional assays can be included as needed.

  • The turnaround is project-dependent and confirmed during consultation. Factors include the number of variants, required yield, and QC assays. We work with you to set a timeline that meets your screening schedule.

  • Yes, custom vectors can be accepted. The details (vector map, resistance markers, promoter) must be reviewed in advance to ensure compatibility with our transient transfection platform.

  • Yield is scoped per project and depends on expression level and throughput. For large panels we commonly target ≥0.2 mg per variant, sufficient for ELISA, Biacore, or cellular assays.

  • Our high-throughput service is designed for early-stage research and screening use. It is not intended for GMP clinical supply. For therapeutic-grade material, separate production processes are required.

Scientific Literature

References

  1. Li D, Partin AC, Zhao L, et al. Protocol for high-throughput cloning, expression, purification, and evaluation of bispecific antibodies. STAR protocols. 2022;3(2):101428. View on PubMed
  2. Hennigan JN, Menacho-Melgar R, Sarkar P, et al. Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control. Metabolic engineering. 2024;85:116-130. View on PubMed
  3. Huang X, Chen W, Zhu S. Expression and Purification of Mammalian NMDA Receptor Protein for Functional Characterization. Methods in molecular biology (Clifton, N.J.). 2024;2799:13-27. View on PubMed
  4. Tiu CK, Zhu F, Wang LF, et al. Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology. Pathogens (Basel, Switzerland). 2022;11(5). View on PubMed
  5. Sturgess KHM, Calero-Nieto FJ, Göttgens B, et al. Single-Cell Analysis of Hematopoietic Stem Cells. Methods in molecular biology (Clifton, N.J.). 2021;2308:301-337. View on PubMed
  6. Hentrich C, Kellmann SJ, Putyrski M, et al. Periplasmic expression of SpyTagged antibody fragments enables rapid modular antibody assembly. Cell chemical biology. 2021;28(6):813-824.e6. View on PubMed

Please kindly note that our products and services are for research use only.